The Supplementary Substance Misuse Treatment and Recovery Grant (SSMTRG), Rough Sleepers Drug and Alcohol Treatment Grant (RSDATG), and Individual Placement Support (IPS) programme collectively enhance core adult substance misuse services by providing targeted additional capacity, specialist workforce roles, and associated operational support. SSMTRG strengthens wider prevention, treatment, and recovery provision through expanded staffing, lived experience delivery, clinical interventions, and infrastructure, while RSDATG focuses specifically on individuals experiencing or at risk of homelessness, funding assertive outreach, clinical care, and tailored engagement to improve access and outcomes. The IPS programme complements treatment by offering intensive, structured employment support to help individuals secure and sustain work, delivered through a defined, high-fidelity model. Across all three programmes, funding covers staffing, clinical and operational costs, and central support functions, with a strong emphasis on flexibility (where applicable), performance management, and partnership working to ensure services respond to demand and deliver positive outcomes for residents.

This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.' Decision makers were members of Bolton Council Public Health. No conflict of Interests or potential conflicts of interest were noted.

The Supplementary Substance Misuse Treatment and Recovery Grant (SSMTRG) provides additional investment to strengthen core adult prevention, treatment and recovery services. It supports an expanded multidisciplinary workforce, including specialist roles in safeguarding, data analysis, quality and compliance, harm reduction, housing, and criminal justice, alongside recovery coordinators and community-led recovery input through a lived experience organisation. Funding also covers associated staff costs, subcontracted service delivery, clinical interventions such as depot buprenorphine, and essential infrastructure including IT, administration, and central contract management. The scope of this additionality is flexible and may be adjusted with commissioners in response to changing needs and available resources. The Rough Sleepers Drug and Alcohol Treatment Grant (RSDATG) is targeted specifically at individuals experiencing, or at risk of, homelessness and rough sleeping. It funds a dedicated treatment and outreach offer, including assertive outreach workers, clinical and psychological support, prescribing capacity, and roles focused on reducing harm and improving engagement. As with SSMTRG, it also supports staffing-related costs, clinical interventions, and the operational infrastructure required to deliver effective services. This programme is similarly adaptable, allowing commissioners to refine delivery in line with demand and priorities. The Individual Placement Support (IPS) programme provides intensive, structured employment support for adults in treatment, helping them secure and sustain work. Delivered through a small, dedicated team, the model offers ongoing, tailored support for both individuals and employers for up to 12 months. Funding covers staffing, associated costs, premises and overheads, and administrative support. Unlike the other programmes, IPS follows a prescribed delivery model to maintain fidelity, meaning it is expected to remain consistent throughout the year. Across all three programmes, there is a shared emphasis on performance management and collaboration between commissioners and providers to ensure services reach eligible residents, respond to increases in treatment demand, and achieve positive, measurable outcomes. This award has been made following Provider Selection Regime (PSR) direct award process A The lifetime value of the contract is £1,989,662 The services will be provided between 01.04.2026 - 31.03.2027 with an option to extend for a further 2 (two) periods of 1 (one) year.

Public Contracts Regulations 2015 (Directive 2014/24/EU)

Award procedure without prior publication of a call for competition The contract is being awarded under Direct Award Process A of the Health Care Services (Provider Selection Regime) Regulations 2023. The services to which this award relates form part of the existing integrated substance misuse treatment and recovery service currently delivered by Waythrough. The Council is satisfied that the services can only be provided by the existing provider due to the nature of the services and the requirement for continuity of care, continuity of treatment pathways and integration with the existing service model. The additional funding is intended to enhance and expand the provision of the existing service and is dependent upon established clinical governance arrangements, workforce capacity, data sharing arrangements, partnership working and service user pathways that are already in place. Following assessment, the Council concluded that there is no realistic alternative provider capable of delivering the services within the required timescales and without significant risk to service continuity, service users, performance, quality and outcomes. The award to the existing provider therefore satisfies the conditions for Direct Award Process A under the Health Care Services (Provider Selection Regime) Regulations 2023

Lot 1: Bids: 1